- PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications
- Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting
- Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
- Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
More ▼
Key statistics
On Friday, Bicycle Therapeutics PLC (BCYC:NSQ) closed at 20.21, -26.51% below its 52-week high of 27.50, set on Jul 17, 2023.
52-week range
Open | 19.53 |
---|---|
High | 20.54 |
Low | 19.27 |
Bid | 20.23 |
Offer | 20.59 |
Previous close | 20.21 |
Average volume | 204.37k |
---|---|
Shares outstanding | 49.71m |
Free float | 11.26m |
P/E (TTM) | -- |
Market cap | 1.00bn USD |
EPS (TTM) | -4.45 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼